Gentian Diagnostics ASA
OSE:GENT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gentian Diagnostics ASA
OSE:GENT
|
NO |
|
C
|
CFM Holdings Ltd
SGX:5EB
|
SG |
|
F
|
Fine Metal Technologies PCL
SET:FMT
|
TH |
|
N
|
Nebius Group NV
DUS:YDX
|
NL |
|
Dalrada Financial Corp
OTC:DFCO
|
US |
Wall St Price Targets
GENT Price Targets Summary
Gentian Diagnostics ASA
According to Wall Street analysts, the average 1-year price target for GENT is 61.2 NOK with a low forecast of 60.6 NOK and a high forecast of 63 NOK.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GENT's stock price target?
Price Target
61.2
NOK
According to Wall Street analysts, the average 1-year price target for GENT is 61.2 NOK with a low forecast of 60.6 NOK and a high forecast of 63 NOK.
What is the Revenue forecast for Gentian Diagnostics ASA?
Projected CAGR
15%
Over the last 9 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 3 years is 15%.
What is the Gross Profit forecast for Gentian Diagnostics ASA?
Projected CAGR
24%
Over the last 9 years, the compound annual growth rate for Gross Profit has been 22%. The projected CAGR for the next 3 years is 24%.
What is the Operating Income forecast for Gentian Diagnostics ASA?
Projected CAGR
31%
The compound annual growth rate for Operating Income over the next 3 years is 31%.
What is the Pre-Tax Income forecast for Gentian Diagnostics ASA?
Projected CAGR
53%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 53%.
What is the Net Income forecast for Gentian Diagnostics ASA?
Projected CAGR
80%
The compound annual growth rate for Net Income over the next 3 years is 80%.
